Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Gets FDA Emergency Use Authorization for Pooled Sample SARS-CoV-2 Test Kit

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Thermo Fisher Scientific's TaqPath COVID-19 Pooling Kit.

The kit is designed to detect the ORF1ab, N, and S genes of SARS-CoV-2 in pooled samples containing up to five individual nasopharyngeal, oropharyngeal, anterior nasal, or mid-turbinate nasal swab specimens collected by healthcare providers. It runs on Thermo Fisher's Applied Biosystems QuantStudio 7 RT-PCR instrument and may be used by any lab that is CLIA-certified to perform high-complexity tests.

In April, Thermo Fisher received EUA from the FDA for a high-throughput, automated SARS-CoV-2 test kit, which is based on the Waltham, Massachusetts-based company's previously authorized Applied Biosystems TaqPath COVID-19 Combo Kit.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.